{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T21:48:13Z","timestamp":1789768093107,"version":"4.0.1"},"reference-count":21,"publisher":"Japanese Society of Internal Medicine","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2025,8,1]]},"DOI":"10.2169\/internalmedicine.4714-24","type":"journal-article","created":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T17:12:10Z","timestamp":1736874730000},"page":"2399-2405","source":"Crossref","is-referenced-by-count":1,"title":["Extensive but Steroid-sensitive Pulmonary Infiltration by Natural Killer-large Granular Lymphocytic Leukemia"],"prefix":"10.2169","volume":"64","author":[{"given":"Masahiro","family":"Tokunaga","sequence":"first","affiliation":[{"name":"Department of Hematology, Suita Municipal Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Tetsumoto","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine and Clinical Immunology, Suita Municipal Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayato","family":"Maruoka","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Kobe City Medical Center General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akito","family":"Miyazaki","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine and Clinical Immunology, Suita Municipal Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Yoshikawa","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Suita Municipal Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuo","family":"Maeda","sequence":"additional","affiliation":[{"name":"Department of Hematology, Suita Municipal Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Morice WG, Cheng CL, Gujral S, et al. NK-large granular lymphocytic leukaemia. In: WHO Classification of Tumours. Haematolymphoid Tumours. 5th ed. WHO Classification of Tumours Editorial Board, Ed. International Agency for Research on Cancer, Lyon, 2024: 665-666."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Zhang J, Wang P, Yan X. Pulmonary infiltration as the initial manifestation of chronic lymphoproliferative disorder of natural killer cells: a case report and literature review. BMC Pulm Med 21: 94, 2021.","DOI":"10.1186\/s12890-021-01457-y"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kurt H, Jorgensen JL, Amin HM, et al. Chronic lymphoproliferative disorder of NK-cells: A single-institution review with emphasis on relative utility of multimodality diagnostic tools. Eur J Haematol 100: 444-454, 2018.","DOI":"10.1111\/ejh.13038"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Oshimi K, Kawa K, Nakamura S, et al. NK-cell neoplasms in Japan. Hematology 10: 237-245, 2005.","DOI":"10.1080\/10245330400026162"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Jerez A, Clemente MJ, Makishima H, et al. STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia. Blood 120: 3048-3057, 2012.","DOI":"10.1182\/blood-2012-06-435297"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Jiang NG, Jin YM, Niu Q, Zeng TT, Su J, Zhu HL. Flow cytometric immunophenotyping is of great value to diagnosis of natural killer cell neoplasms involving bone marrow and peripheral blood. Ann Hematol 92: 89-96, 2013.","DOI":"10.1007\/s00277-012-1574-3"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Gattazzo C, Teramo A, Passeri F, et al. Detection of monoclonal T populations in patients with KIR-restricted chronic lymphoproliferative disorder of NK cells. Haematologica 99: 1826-1833, 2014.","DOI":"10.3324\/haematol.2014.105726"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Lima M, Almeida J, Montero AG, et al. Clinicobiological, immunophenotypic, and molecular characteristics of monoclonal CD56-\/+dim chronic natural killer cell large granular lymphocytosis. Am J Pathol 165: 1117-1127, 2004.","DOI":"10.1016\/S0002-9440(10)63373-1"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Poullot E, Zambello R, Leblanc F, et al. Chronic natural killer lymphoproliferative disorders: characteristics of an international cohort of 70 patients. Ann Oncol 25: 2030-2035, 2014.","DOI":"10.1093\/annonc\/mdu369"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Baril\u00e0 G, Teramo A, Calabretto G, et al. Dominant cytotoxic NK cell subset within CLPD-NK patients identifies a more aggressive NK cell proliferation. Blood Cancer J 8: 51, 2018.","DOI":"10.1038\/s41408-018-0088-1"},{"key":"11","unstructured":"11. Villamor N, Morice WG, Chan WC, Foucar K. Chronic lymphoproliferative disorder of NK cells. In: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Revised 4th ed. Swerdlow SH, Campo E, Harris NL, et al., Eds. International Agency for Research on Cancer, Lyon, 2017: 351-352."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Meier T, Eulenbruch HP, Wrighton-Smith P, Enders G, Regnath T. Sensitivity of a new commercial enzyme-linked immunospot assay (T SPOT-TB) for diagnosis of tuberculosis in clinical practice. Eur J Clin Microbiol Infect Dis 24: 529-536, 2005.","DOI":"10.1007\/s10096-005-1377-8"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Hoffmann T, De Libero G, Colonna M, et al. Natural killer-type receptors for HLA class I antigens are clonally expressed in lymphoproliferative disorders of natural killer and T-cell type. Br J Haematol 110: 525-536, 2000.","DOI":"10.1046\/j.1365-2141.2000.02159.x"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Morice WG, Kurtin PJ, Leibson PJ, Tefferi A, Hanson CA. Demonstration of aberrant T-cell and natural killer-cell antigen expression in all cases of granular lymphocytic leukaemia. Br J Haematol 120: 1026-1036, 2003.","DOI":"10.1046\/j.1365-2141.2003.04201.x"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Woyach JA, Smucker K, Smith LL, et al. Prolonged lymphocytosis during ibrutinib therapy is associated with distinct molecular characteristics and does not indicate a suboptimal response to therapy. Blood 123: 1810-1817, 2014.","DOI":"10.1182\/blood-2013-09-527853"},{"key":"16","unstructured":"16. Arai A. Diagnosis and management of EBV-positive lymphoproliferative disorders. Rinsho Ketsueki (Jpn J Clin Hematol) 64: 764-771, 2023."},{"key":"17","unstructured":"17. Araujo I, Kimura H, Liu WP, Sang\u00fceza OP. Systemic chronic active EBV disease. In: WHO Classification of Tumours. Haematolymphoid Tumours. 5th ed. WHO Classification of Tumours Editorial Board, Ed. International Agency for Research on Cancer, Lyon, 2024: 777-778."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Pastoret C, Desmots F, Drillet G, et al. Linking the KIR phenotype with <i>STAT3<\/i> and <i>TET2<\/i> mutations to identify chronic lymphoproliferative disorders of NK cells. Blood 137: 3237-3250, 2021.","DOI":"10.1182\/blood.2020006721"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Baer C, Kimura S, Rana MS, et al. <i>CCL22<\/i> mutations drive natural killer cell lymphoproliferative disease by deregulating microenvironmental crosstalk. Nat Genet 54: 637-648, 2022.","DOI":"10.1038\/s41588-022-01059-2"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Rajala HL, Eldfors S, Kuusanm\u00e4ki H, et al. Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia. Blood 121: 4541-4550, 2013.","DOI":"10.1182\/blood-2012-12-474577"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. de Mel S, Li JB, Abid MB, et al. The utility of flow cytometry in differentiating NK\/T cell lymphoma from indolent and reactive NK cell proliferations. Cytometry B Clin Cytom 94: 159-168, 2018.","DOI":"10.1002\/cyto.b.21529"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/15\/64_4714-24\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T04:15:40Z","timestamp":1754108140000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/15\/64_4714-24\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":21,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.4714-24","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,1]]},"article-number":"4714-24"}}